PortfoliosLab logoPortfoliosLab logo
OLMA vs. ARDX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

OLMA vs. ARDX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Olema Pharmaceuticals, Inc. (OLMA) and Ardelyx, Inc. (ARDX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, OLMA achieves a -57.24% return, which is significantly lower than ARDX's -5.32% return.


OLMA

1D
-15.89%
1M
-25.35%
YTD
-57.24%
6M
-60.63%
1Y
144.34%
3Y*
23.54%
5Y*
-17.30%
10Y*

ARDX

1D
-3.66%
1M
-19.77%
YTD
-5.32%
6M
-0.36%
1Y
43.38%
3Y*
16.18%
5Y*
-4.31%
10Y*
-4.80%
*Multi-year figures are annualized to reflect compound growth (CAGR)

OLMA vs. ARDX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
OLMA
Olema Pharmaceuticals, Inc.
-57.24%328.82%-58.45%472.65%-73.82%-80.53%-1.88%
ARDX
Ardelyx, Inc.
-5.32%14.99%-18.23%117.54%159.09%-83.00%13.31%

Correlation

The correlation between OLMA and ARDX is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.27

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Nov 20, 2020

0.26

Fundamentals

Market Cap

OLMA:

$1.10B

ARDX:

$1.36B

EPS

OLMA:

-$2.03

ARDX:

-$0.24

PB Ratio

OLMA:

2.29

ARDX:

9.13

Total Revenue (TTM)

OLMA:

$0.00

ARDX:

$427.68M

Gross Profit (TTM)

OLMA:

-$187.00K

ARDX:

$395.63M

EBITDA (TTM)

OLMA:

-$197.79M

ARDX:

-$28.55M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OLMA vs. ARDX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OLMA
OLMA Risk / Return Rank: 7676
Overall Rank
OLMA Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
OLMA Sortino Ratio Rank: 9090
Sortino Ratio Rank
OLMA Omega Ratio Rank: 8888
Omega Ratio Rank
OLMA Calmar Ratio Rank: 6868
Calmar Ratio Rank
OLMA Martin Ratio Rank: 6666
Martin Ratio Rank

ARDX
ARDX Risk / Return Rank: 6565
Overall Rank
ARDX Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
ARDX Sortino Ratio Rank: 6666
Sortino Ratio Rank
ARDX Omega Ratio Rank: 6363
Omega Ratio Rank
ARDX Calmar Ratio Rank: 6868
Calmar Ratio Rank
ARDX Martin Ratio Rank: 6767
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OLMA vs. ARDX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Olema Pharmaceuticals, Inc. (OLMA) and Ardelyx, Inc. (ARDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OLMAARDXDifference

Sharpe ratio

Return per unit of total volatility

0.90

0.71

+0.20

Sortino ratio

Return per unit of downside risk

3.26

1.59

+1.67

Omega ratio

Gain probability vs. loss probability

1.41

1.19

+0.22

Calmar ratio

Return relative to maximum drawdown

1.46

1.50

-0.04

Martin ratio

Return relative to average drawdown

3.12

3.14

-0.02

OLMA vs. ARDX - Sharpe Ratio Comparison

The current OLMA Sharpe Ratio is 0.90, which is comparable to the ARDX Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of OLMA and ARDX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


OLMAARDXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.90

0.71

+0.20

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.16

-0.05

-0.11

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.06

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.23

-0.09

-0.14

Drawdowns

OLMA vs. ARDX - Drawdown Comparison

The maximum OLMA drawdown since its inception was -96.26%, roughly equal to the maximum ARDX drawdown of -98.45%. Use the drawdown chart below to compare losses from any high point for OLMA and ARDX.


Loading charts...

Drawdown Indicators


OLMAARDXDifference

Max Drawdown

Largest peak-to-trough decline

-96.26%

-98.45%

+2.19%

Max Drawdown (1Y)

Largest decline over 1 year

-70.16%

-33.54%

-36.62%

Max Drawdown (3Y)

Largest decline over 3 years

-82.15%

-66.32%

-15.83%

Max Drawdown (5Y)

Largest decline over 5 years

-93.36%

-93.76%

+0.40%

Max Drawdown (10Y)

Largest decline over 10 years

-96.82%

Current Drawdown

Current decline from peak

-80.39%

-83.22%

+2.83%

Average Drawdown

Average peak-to-trough decline

-74.98%

-77.37%

+2.39%

Ulcer Index

Depth and duration of drawdowns from previous peaks

32.85%

16.08%

+16.77%

Volatility

OLMA vs. ARDX - Volatility Comparison

Olema Pharmaceuticals, Inc. (OLMA) has a higher volatility of 21.98% compared to Ardelyx, Inc. (ARDX) at 12.69%. This indicates that OLMA's price experiences larger fluctuations and is considered to be riskier than ARDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


OLMAARDXDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.98%

12.69%

+9.29%

Volatility (6M)

Calculated over the trailing 6-month period

55.92%

46.59%

+9.33%

Volatility (1Y)

Calculated over the trailing 1-year period

161.50%

61.62%

+99.88%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

107.97%

89.42%

+18.55%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

106.45%

84.10%

+22.35%

Dividends

OLMA vs. ARDX - Dividend Comparison

Neither OLMA nor ARDX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

OLMA vs. ARDX - Financials Comparison

This section allows you to compare key financial metrics between Olema Pharmaceuticals, Inc. and Ardelyx, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00M120.00M202220232024202520260
94.47M
(OLMA) Total Revenue
(ARDX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


OLMA and ARDX have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

OLMA has higher volatility (21.98%) compared to ARDX (12.69%). In terms of maximum drawdown, OLMA dropped -96.26% vs ARDX's -98.45%.

OLMA currently has the higher Sharpe Ratio (0.90 vs 0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for OLMA and ARDX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer